Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Crenshaw, W. B.
Right arrow Articles by Clouse, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Crenshaw, W. B.
Right arrow Articles by Clouse, M. E.

Radiology, Vol 200, 185-192, Copyright © 1996 by Radiological Society of North America

ARTICLES

Severe ascites: efficacy of the transjugular intrahepatic portosystemic shunt in treatment

WB Crenshaw, FD Gordon, NJ McEniff, LJ Perry, G Hartnell, H Anastopoulos, RL Jenkins, WD Lewis, HG Wheeler and ME Clouse
Department of Radiological Sciences, Deaconess Hospital, Boston, Mass, USA.

PURPOSE: To evaluate the transjugular intrahepatic portosystemic shunt (TIPS) as primary treatment in patients with cirrhosis and severe ascites. MATERIALS AND METHODS: A TIPS placement was attempted in 54 consecutive patients with intractable ascites. Clinical assessment findings, shunt patency, complications, and survival were analyzed. RESULTS: A TIPS was successfully placed in 50 patients (93%). Follow-up for clinical effectiveness in 51 patients was a mean of 285 days (range, 1-981 days). Forty patients (78%) gained clinical benefit from the shunt. Of these, 29 (57%) had a complete response (required no further paracentesis) and 11 patients (22%) had a partial response (required less frequent but additional paracentesis for control of ascites). The absence of preprocedure renal insufficiency (creatinine < 1.5 mg/dL [< 130 mumol/L]) was the only characteristic identified as an indicator of clinical success (P < .05). Eleven patients (22%) required shunt revision during follow-up to gain or prolong control of symptoms. Cumulative survival in the population evaluated for clinical efficacy was 53% at 6 months and 48% at 1 year. A complete response was the only variable that indicated increased survival (P < .05; R2 = 12%) with a 6- month survival rate of 76% and a 1-year rate of 71%. CONCLUSION: TIPS placement appears to be effective as a primary treatment of patients with cirrhosis and severe ascites.


This article has been cited by other articles:


Home page
 GutHome page
K P Moore and G P Aithal
Guidelines on the management of ascites in cirrhosis
Gut, October 1, 2006; 55(suppl_6): vi1 - vi12.
[Full Text] [PDF]

Home page
 QJMHome page
H. Suzuki and A.J. Stanley
Current management and novel therapeutic strategies for refractory ascites and hepatorenal syndrome
QJM, June 1, 2001; 94(6): 293 - 300.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
M. Rossle, A. Ochs, V. Gulberg, V. Siegerstetter, J. Holl, P. Deibert, M. Olschewski, M. Reiser, and A. L. Gerbes
A Comparison of Paracentesis and Transjugular Intrahepatic Portosystemic Shunting in Patients with Ascites
N. Engl. J. Med., June 8, 2000; 342(23): 1701 - 1707.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
R JALAN, H F LUI, D N REDHEAD, and P C HAYES
TIPSS 10 years on
Gut, April 1, 2000; 46(4): 578 - 581.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 1996 by the Radiological Society of North America.